Megalin-mediated endocytosis of cystatin C in proximal tubule cells

Biochemical and Biophysical Research Communications

Volumn 357, Issue 4, 2007, Pages 1130-1134

  Kaseda, Ryohei ^a   Iino, Noriaki ^a   Hosojima, Michihiro ^a   Takeda, Tetsuro ^a   Hosaka, Kiyoko ^a   Kobayashi, Asako ^a   Yamamoto, Keiko ^a   Suzuki, Akiyo ^a   Kasai, Ayaka ^a   Suzuki, Yoshiki ^b   Gejyo, Fumitake ^a   Saito, Akihiko ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Cystatin C; Cysteine proteinase inhibitor; Endocytosis; Glomerular filtration rate; Megalin; Proximal tubule cell; Quartz crystal microbalance

Indexed keywords

CALCIUM; CYSTATIN C; MEGALIN; SILICON DIOXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; KIDNEY TUBULE CELL; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; RAT; YOLK SAC;

ANIMALS; CELL LINE; CYSTATINS; ENDOCYTOSIS; EPITHELIAL CELLS; KIDNEY TUBULES, PROXIMAL; LDL-RECEPTOR RELATED PROTEIN 2; MICE; MICE, KNOCKOUT; RATS;

MUS; RATTUS;

EID: 34247857734     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.072     Document Type: Article

References (32)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., Parfrey P., Pfeffer M., Raij L., Spinosa D.J., and Wilson P.W. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
2. Taal M.W., and Brenner B.M. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 70 (2006) 1694-1705
3. Heymsfield S.B., Arteaga C., McManus C., Smith J., and Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am. J. Clin. Nutr. 37 (1983) 478-494
4. James G.D., Sealey J.E., Alderman M., Ljungman S., Mueller F.B., Pecker M.S., and Laragh J.H. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am. J. Hypertens. 1 (1988) 124-131
5. Kazama J.J., Kutsuwada K., Ataka K., Maruyama H., and Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 91 (2002) 13-20
6. Filler G., Bokenkamp A., Hofmann W., Le Bricon T., Martinez-Bru C., and Grubb A. Cystatin C as a marker of GFR--history, indications, and future research. Clin. Biochem. 38 (2005) 1-8
7. Bokenkamp A., Herget-Rosenthal S., and Bokenkamp R. Cystatin C, kidney function and cardiovascular disease. Pediatr. Nephrol. 21 (2006) 1223-1230
8. Roos J.F., Doust J., Tett S.E., and Kirkpatrick C.M. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-A meta-analysis. Clin. Biochem. 40 (2007) 383-391
9. Abrahamson M., Olafsson I., Palsdottir A., Ulvsback M., Lundwall A., Jensson O., and Grubb A. Structure and expression of the human cystatin C gene. Biochem. J. 268 (1990) 287-294
10. Tenstad O., Roald A.B., Grubb A., and Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J. Clin. Lab. Invest. 56 (1996) 409-414
11. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 38 Suppl. 1 (1992) S20-S27
12. Saito A., Pietromonaco S., Loo A.K., and Farquhar M.G. Complete cloning and sequencing of rat gp330/"megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 91 (1994) 9725-9729
13. Farquhar M.G., Saito A., Kerjaschki D., and Orlando R.A. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J. Am. Soc. Nephrol. 6 (1995) 35-47
14. Christensen E.I., and Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 256-266
15. Hama H., Saito A., Takeda T., Tanuma A., Xie Y., Sato K., Kazama J.J., and Gejyo F. Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology 145 (2004) 3935-3940
16. Oyama Y., Takeda T., Hama H., Tanuma A., Iino N., Sato K., Kaseda R., Ma M., Yamamoto T., Fujii H., Kazama J.J., Odani S., Terada Y., Mizuta K., Gejyo F., and Saito A. Evidence for megalin-mediated proximal tubular uptake of l-FABP, a carrier of potentially nephrotoxic molecules. Lab. Invest. 85 (2005) 522-531
17. Czekay R.P., Orlando R.A., Woodward L., Lundstrom M., and Farquhar M.G. Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes. Mol. Biol. Cell 8 (1997) 517-532
18. Orlando R.A., and Farquhar M.G. Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex. Proc. Natl. Acad. Sci. USA 90 (1993) 4082-4086
19. Leheste J.R., Melsen F., Wellner M., Jansen P., Schlichting U., Renner-Muller I., Andreassen T.T., Wolf E., Bachmann S., Nykjaer A., and Willnow T.E. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J. 17 (2003) 247-249
20. Leheste J.R., Rolinski B., Vorum H., Hilpert J., Nykjaer A., Jacobsen C., Aucouturier P., Moskaug J.O., Otto A., Christensen E.I., and Willnow T.E. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 155 (1999) 1361-1370
21. Trollfors B., and Norrby R. Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin. Nephron 28 (1981) 196-199
22. Sturfelt G., Truedsson L., Thysell H., and Bjorck L. Serum level of complement factor D in systemic lupus erythematosus-an indicator of glomerular filtration rate. Acta. Med. Scand. 216 (1984) 171-177
23. Jayagopal V., Keevil B.G., Atkin S.L., Jennings P.E., and Kilpatrick E.S. Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism. Clin. Chem. 49 (2003) 680-681
24. Fricker M., Wiesli P., Brandle M., Schwegler B., and Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 63 (2003) 1944-1947
25. Risch L., and Huber A.R. Glucocorticoids and increased serum cystatin C concentrations. Clin. Chim. Acta 320 (2002) 133-134
26. Konopska B., Gburek J., Golab K., and Warwas M. Characterization of chicken cystatin binding to rat renal brush-border membranes. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 146 (2007) 482-488
27. Marino M., Zheng G., Chiovato L., Pinchera A., Brown D., Andrews D., and McCluskey R.T. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J. Biol. Chem. 275 (2000) 7125-7137
28. Marino M., Andrews D., Brown D., and McCluskey R.T. Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J. Am. Soc. Nephrol. 12 (2001) 637-648
29. Olbricht C.J., and Geissinger B. Renal hypertrophy in streptozotocin diabetic rats: role of proteolytic lysosomal enzymes. Kidney Int. 41 (1992) 966-972
30. Shechter P., Boner G., and Rabkin R. Tubular cell protein degradation in early diabetic renal hypertrophy. J. Am. Soc. Nephrol. 4 (1994) 1582-1587
31. George P.M., and Sheat J.M. Cystatin C quantification in CSF. Clin. Chem. 35 (1989) 179-180
32. Grubb A.O., Weiber H., and Lofberg H. The gamma-trace concentration of normal human seminal plasma is thirty-six times that of normal human blood plasma. Scand. J. Clin. Lab. Invest. 43 (1983) 421-425